Insight on Pharmaceuticals and Healthcare

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Report
Report

Brazil Pharmaceutical Market Overview – Strong market growth continues, but regulatory risks increase

Overview of the pharmaceutical market in Brazil including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis, and pharmaceutical market and pharmaceutical company infrastructure analysis.

Published By Datamonitor
21 Sep 2012 $2800
Buy
Report
Report

BRIC: Pricing, Reimbursement, and Regulatory Update

Datamonitor’s report BRIC: Pricing, Reimbursement, and Regulatory Update provides an update of changes to pricing, reimbursement and regulation in Brazil, Russia, India and China during the first half of 2011.

Published By Datamonitor
08 Sep 2011 $1520
Buy
Brief
Brief

Brief: Hepatitis C/AASLD 2010

This brief is an overview of the HCV highlights from the 2010 American Association of the Study of Liver Disease meeting. It discusses pivotal data for telaprevir and boceprevir, results for TMC435 and data from interferon-sparing studies.

Published By Datamonitor
13 Dec 2010 $400
Buy
Report
Report

Bristol-Myers Squibb Co.: Company Analysis

Analysis of BMS's corporate strategy, marketed portfolio, pipeline potential and financial position in 2011 and to 2017

Published By Datamonitor
08 Aug 2012 $2800
Buy
Report
Report

Bydureon FDA Approval: Physician Opinion

Physician survey of 84 endocrinologists and primary care physicians on their impressions and expected use of Amylin’s and Alkermes’s Bydureon (once-weekly exenatide)

Published By Datamonitor
24 Feb 2012 $2800
Buy
Report
Report

Canada: Generics and Biosimilars Overview

Overview of the generics and biosimilars landscape including, regulatory issues, drivers and resistors to uptake, level of penetration, and key players operating in the market.

Published By Datamonitor
03 Nov 2011 $1520
Buy
Report
Report

Canada: Healthcare System and Drug Regulatory Overview

This report provides an overview of the insurance and healthcare system, healthcare reforms, drug regulation and intellectual property, and drug pricing and reimbursement in Canada.

Published By Datamonitor
15 Dec 2011 $1520
Buy
Report
Report

Canada: Pharmaceutical Industry Infrastructure Overview

This report provides an overview of research and development, manufacturing, outsourcing, and distribution trends, as well as infrastructure profiles for the leading pharmaceutical companies in Canada.

Published By Datamonitor
16 Dec 2011 $1520
Buy
Report
Report

Cardiovascular and Metabolic Diseases Market Access in China – Managing challenges to harness growing commercial potential

The large number of Chinese CV & metabolic diseases patients brings significant commercial opportunities for Pharma. Plans to expand insurance coverage and improve healthcare infrastructure will enhance therapy access, boosting the market potential.

Published By Datamonitor
09 Dec 2011 $2800
Buy
Report
Report

Case Study: Autism Spectrum Disorders – Public awareness and physician detailing will drive market growth

This report examines the opportunities and threats within the autism spectrum disorders (ASDs) market. The analysis is intended to support company strategy and decision-making by providing actionable recommendations in the current treatment pathway.

Published By Datamonitor
16 Apr 2012 $1520
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.